BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33719846)

  • 21. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
    Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
    Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect and mechanism of microRNA-21 on cis-dichlorodiamineplatinum resistance in lung cancer cell strain].
    Ren L; Huang C; Liu YH; Yu Y; Lin L; Wen LJ
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1454-8. PubMed ID: 27266356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of Id3 inhibits cell proliferation and induces apoptosis in A549/DDP human lung cancer cells in vitro.
    Chen F; Zhao Q; Wang S; Wang H; Li X
    Mol Med Rep; 2016 Jul; 14(1):313-8. PubMed ID: 27176047
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Xu C; Li Y; Pan J; Wang S; Ye Z; Cai X; Zheng H; Yin Z; Cao Z
    Discov Med; 2024 Jan; 36(180):82-90. PubMed ID: 38273748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding LUCAT1 promotes cisplatin resistance of non-small cell lung cancer by promoting IGF-2.
    Wang W; Dong ML; Zhang W; Liu T
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5229-5234. PubMed ID: 31298373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells.
    Yu G; Zhong N; Chen G; Huang B; Wu S
    Tumour Biol; 2014 Oct; 35(10):10341-9. PubMed ID: 25038915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblasts from patients with idiopathic pulmonary fibrosis are resistant to cisplatin-induced cell death via enhanced CK2-dependent XRCC1 activity.
    Im J; Nho RS
    Apoptosis; 2019 Jun; 24(5-6):499-510. PubMed ID: 30850922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways.
    Wang Y; Liu X; Liu J; Zhang T
    Cancer Biother Radiopharm; 2019 Aug; 34(6):362-370. PubMed ID: 30973271
    [No Abstract]   [Full Text] [Related]  

  • 29. [Enhancement effect of nucleotide excision repair gene xeroderma pigmentosun group a antisense RNA on sensitivity of human lung adenocarcinoma cell line A549 to cisplatin].
    Fan W; Zhang HL; Wu XM
    Ai Zheng; 2005 Apr; 24(4):403-7. PubMed ID: 15820060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells.
    Xu L; Fu Y; Li Y; Han X
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):235-242. PubMed ID: 28597042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].
    Zhang MC; Hu CP; Chen Q
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. X-ray repair cross-complementing protein 1 (XRCC1) loss promotes β-lapachone -induced apoptosis in pancreatic cancer cells.
    Zheng Y; Zhang H; Guo Y; Chen Y; Chen H; Liu Y
    BMC Cancer; 2021 Nov; 21(1):1234. PubMed ID: 34789190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [PPAR-γ silencing inhibits the apoptosis of A549 cells by upregulating Bcl-2].
    Yang J
    Zhongguo Fei Ai Za Zhi; 2013 Mar; 16(3):125-30. PubMed ID: 23514940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of DNA Repair and Drug Transporter in Relation to Chemosensitivity in Primary Culture of Thai Gastric Cancer Patients.
    Wongsirisin P; Limpakan Yamada S; Yodkeeree S; Punfa W; Limtrakul P
    Biol Pharm Bull; 2018; 41(3):360-367. PubMed ID: 29491212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of miR-1244 on cisplatin-treated non-small cell lung cancer via MEF2D expression.
    Li GJ; Zhao GQ; Yang JP; Zhou YC; Yang KY; Lei YJ; Huang YC
    Oncol Rep; 2017 Jun; 37(6):3475-3483. PubMed ID: 28498474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propofol Improves Sensitivity of Lung Cancer Cells to Cisplatin and Its Mechanism.
    Huang Y; Lei L; Liu Y
    Med Sci Monit; 2020 Mar; 26():e919786. PubMed ID: 32225124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of caspases, Bax and Bcl-2 in chrysin-induced apoptosis in the A549 human lung adenocarcinoma epithelial cells.
    Samarghandian S; Nezhad MA; Mohammadi G
    Anticancer Agents Med Chem; 2014; 14(6):901-9. PubMed ID: 24521149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8.
    Zhang Z; Zhang L; Yin ZY; Fan XL; Hu B; Wang LQ; Zhang D
    Int J Clin Exp Pathol; 2014; 7(10):7236-41. PubMed ID: 25400821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decrease in susceptibility toward induction of apoptosis and alteration in G1 checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-Hydroxystaurosporine).
    Sugiyama K; Akiyama T; Shimizu M; Tamaoki T; Courage C; Gescher A; Akinaga S
    Cancer Res; 1999 Sep; 59(17):4406-12. PubMed ID: 10485490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baicalin, a Chinese Herbal Medicine, Inhibits the Proliferation and Migration of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells, A549 and H1299, by Activating the SIRT1/AMPK Signaling Pathway.
    You J; Cheng J; Yu B; Duan C; Peng J
    Med Sci Monit; 2018 Apr; 24():2126-2133. PubMed ID: 29632297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.